Literature DB >> 6838251

Pre-excitation syndrome in infants and children. Effect of digoxin, verapamil, and amiodarone.

E Shahar, Z Barzilay, A A Shem-Tov, I Shohet, M Frand.   

Abstract

Clinical and electrocardiographic findings for 30 patients with the pre-excitation syndrome are described together with details of treatment. Nineteen (63%) were younger than 2 years, 14 of whom were under 2 months. Sixteen infants and 7 children (77%) presented with paroxysmal supraventricular tachycardia, 14 (61%) of whom had the electrocardiographic pattern of type A Wolff-Parkinson-White (WPW) syndrome. During paroxysmal bouts the QRS complex was normal in 21 patients and wide in two. Six (20%) patients had congenital heart disease often associated with WPW syndrome type B. Seventeen patients were treated with either digoxin or verapamil intravenously to stop tachyarrhythmias. Verapamil was more effective due to the immediate response and lack of adverse effects. The tachyarrhythmias resolved in all the patients and in some of them the WPW pattern resolved later indicating maturation of the conduction tissue with loss of the accessory pathways. Verapamil provides a rapid and safe form of treatment for conversion of tachyarrhythmias since it has no effect on the accessory pathways. Oral amiodarone prevents recurrent tachyarrhythmias resistant to other treatment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6838251      PMCID: PMC1627806          DOI: 10.1136/adc.58.3.207

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  23 in total

1.  PAROXYSMAL ATRIAL FIBRILLATION IN WOLFF-PARKINSON-WHITE SYNDROME SIMULATING VENTRICULAR TACHYCARDIA.

Authors:  J H YAHINI; I ZAHAVI; H N NEUFELD
Journal:  Am J Cardiol       Date:  1964-08       Impact factor: 2.778

2.  The Wolff-Parkinson-White syndrome in infancy and childhood.

Authors:  J SWIDERSKI; M H LEES; A S NADAS
Journal:  Br Heart J       Date:  1962-09

3.  Accessory atrioventricular muscle bundles of the developing human heart.

Authors:  R C TRUEX; J K BISHOF; E L HOFFMAN
Journal:  Anat Rec       Date:  1958-05

4.  Tachyarrhythmias in Wolff-Parkinson-White syndrome. Treatment and prevention.

Authors:  A M Tonkin; J J Gallagher; A G Wallace
Journal:  JAMA       Date:  1976-03-01       Impact factor: 56.272

5.  Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome.

Authors:  R A Spurrell; D M Krikler; E Sowton
Journal:  Br Heart J       Date:  1974-03

6.  Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride.

Authors:  M B Rosenbaum; P A Chiale; D Ryba; M V Elizari
Journal:  Am J Cardiol       Date:  1974-08       Impact factor: 2.778

Review 7.  The Wolff-Parkinson-White syndrome: evolving concepts of its pathogenesis.

Authors:  T N James
Journal:  Prog Cardiovasc Dis       Date:  1970-09       Impact factor: 8.194

8.  Effect of digitalis on atrioventricular conduction and circus-movement tachycardias in patients with Wolff-Parkinson-White syndrome.

Authors:  H J Wellens; D Durrer
Journal:  Circulation       Date:  1973-06       Impact factor: 29.690

9.  The Wolff-Parkinson-White syndrome in infants and children. A review and a report of 28 cases.

Authors:  G L SCHIEBLER; P ADAMS; R C ANDERSON
Journal:  Pediatrics       Date:  1959-10       Impact factor: 7.124

10.  Wolff-Parkinson-White syndrome in infants and children. A long-term follow-up study.

Authors:  A C Giardina; K H Ehlers; M A Engle
Journal:  Br Heart J       Date:  1972-08
View more
  5 in total

Review 1.  Anaesthesia and Wolff-Parkinson-White syndrome during infancy: a review.

Authors:  D R Goldhill; E D Latosa; E Facer
Journal:  J R Soc Med       Date:  1988-06       Impact factor: 5.344

2.  Effect on growth of children with cardiac dysrhythmias treated with amiodarone.

Authors:  J Ardura; F Hermoso; J Bermejo
Journal:  Pediatr Cardiol       Date:  1988       Impact factor: 1.655

3.  Management of paroxysmal tachycardia.

Authors:  J L Wilkinson
Journal:  Arch Dis Child       Date:  1983-12       Impact factor: 3.791

4.  Efficacy and safety of intravenous amiodarone for short-term treatment of paroxysmal supraventricular tachycardia in children.

Authors:  J A Soult; M Muñoz; J D Lopez; A Romero; J Santos; A Tovaruela
Journal:  Pediatr Cardiol       Date:  1995 Jan-Feb       Impact factor: 1.655

Review 5.  Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

Authors:  J Gill; R C Heel; A Fitton
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.